Close X
Attorney Spotlight

How does Jessie Zeigler anticipate the intersection of privacy and smart technology will impact the future of litigation? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Primary Care Providers Win Challenge of CMS Interpretation of Enhanced Payment Law

With the help and support of the Tennessee Medical Association, 21 Tennessee physicians of underserved communities joined together and retained Bass, Berry & Sims to file suit against the Centers for Medicare & Medicaid Services to stop improper collection efforts. Our team, led by David King, was successful in halting efforts to recoup TennCare payments that were used legitimately to expand services in communities that needed them. Read more

Tennessee Medical Association & Bass, Berry & Sims

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Healthcare Private Equity Compliance Checklist

The complex and ever-changing healthcare regulatory and enforcement environment, including increased focus on the role of private equity firms in their portfolio companies, make compliance a top priority for private equity firms investing in healthcare companies. The best way to limit your exposure as a private equity firm is to avoid a compliance misstep in the first place. Additionally, an effective and robust compliance program for your portfolio healthcare company makes it much more attractive to potential buyers and helps you avoid an unexpected and costly investigation or valuation hit down the road. Download the Healthcare Private Equity Compliance Checklist to assess whether your portfolio company's compliance program is up-to-date.

Click here to download the checklist.

Headaches and Hot Spots: A Review of the Changing World of M&A in the Global Aerospace and Defense Industry

Events

October 20, 2015

Attorney Todd Overman will speak during the session titled "Headaches and Hot Spots: A Review of the Changing World of M&A in the Global Aerospace and Defense Industry" at the 2015 Fall Meeting hosted by the International Law Section of the American Bar Association.

Over the past year, the global market for military products and large-scale projects has seen an overall global decline in revenues and earnings while the commercial aerospace industry has continued to see growth; both see heightened competition for suitors for corporate transactions. In the face of this outlook, there have been major industry consolidations, mergers and transformation initiatives in North America, Europe and Asia, trends which will be highlighted during this session. Economies in certain "hot spots" have seen a sheltering of defense suppliers with greater M&A activity as a result. These hot spots are important for counsel to understand in order to properly advise their internal and external A&DI client. These times produce new "headaches" for in-house counsel and their hired outside advisors. Globally, the role counsel plays in shepherding M&A during tougher times necessitates an understanding of emerging risks and related strategies as well as requires counsel to sharpen their intuition with respect to a myriad of ethical and professional practice issues.

The 2015 Fall Meeting will be held on October 20-24, 2015 in Montreal, Canada at Fairmont the Queen Elizabeth. To learn more, visit the ABA website.


Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.